Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renin Angiotensin System Blockage-DN (RASS)
NCT00143949Phase 2Completed
- Start
- Mar 1997
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in diabetic nephropathy (DN) comparing Enalapril with Losartan (2 arms). Primary endpoint: Development of histologic change in the kidney associated with diabetic nephropathy at 5 years. Started Mar 1997; status: completed.
02
Drugs
enalaprillosartan
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00143949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143949.